Want to know what's happening next in healthcare?

MedCityNews is the leading online news source for the business of innovation in healthcare.


“I find MedCity News a great resource for taking the pulse of the market and sourcing potential investment opportunities.”

Bernie Rudnick, Angel investor and advisor, CapGenic Advisors, LLC


Sign up for our daily newsletter


Medtronic’s new heart valve replacement system gets FDA approval

January 17, 2014 11:04 am by | 1 Comments

Medtronic logo GOOD

(Reuters) - Medtronic Inc's non-invasive systems for replacing diseased heart valves won U.S. approval for use in patients deemed too frail to endure traditional open heart surgery, the U.S. medical device maker said on Friday.

The Food and Drug Administration approved Medtronic's CoreValve system based on U.S. clinical trials in which it was shown to be safe and effective while demonstrating low rates of stroke and valve leakage, the company said.

CoreValve, in which the heart valve replacement is threaded into place through an artery using a catheter, spares patients chest-cracking surgery. The system has been available since 2007 in Europe, where it is not uncommon for medical devices to win approval several years ahead of the United States.

(Reporting by Bill Berkrot; Editing by Lisa Von Ahn)

Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
1 comments
Olani
Olani

Great article other than the use of the phrase "chest cracking". This vivid description was a little too graphic for "yours truly". Almost led to a fainting spell. Please show some sensitivity in choice of words...........otherwise good article.

Hear the latest news first

Get our daily newsletter or follow us.

Advertisement